Beam Therapeutics Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $139.7 | $63.5 | $377.7 | $60.9 | $51.8 |
| Operating income | -$383.7 | -$415.6 | -$176.5 | -$338.5 | -$392.5 |
| Net income | -$80.0 | -$376.7 | -$132.5 | -$289.1 | -$370.6 |
| Cash Flow Statement | |||||
| Free cash flow | -$360.0 | -$356.2 | -$182.9 | -$26.4 | -$113.1 |
Shares outstanding 103.3M · Free float 94.5%
Annual filing data through FY ended December 31, 2025; float as of October 4, 2026.